Global Nucleic Acid-based Therapeutics Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Nucleic Acid-based Therapeutics Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Market Overview:

The latest research study on the global Nucleic Acid-based Therapeutics market finds that the global Nucleic Acid-based Therapeutics market reached a value of USD 43911.41 million in 2022. It’s expected that the market will achieve USD 23040.99 million by 2028, exhibiting a CAGR of -10.19% during the forecast period.

Company Overview:

Pfizer is one of the major players operating in the Nucleic Acid-based Therapeutics market, holding a share of 54.53% in 2021.

Pfizer

Pfizer is a multinational pharmaceutical and biotechnology company originating from the United States, with its operating headquarters in New York and its R&D headquarters in Groton, Connecticut. Its stock became a constituent stock of the Dow Jones Industrial Index on April 8, 2004. According to revenue ranking, it is the world's largest pharmaceutical company.

Moderna Therapeutics

Modena, a multinational pharmaceutical and biotechnology company headquartered in Cambridge, Massachusetts, focuses on cancer immunotherapy, including mRNA-based drug discovery, drug development and vaccine technology.

Segmentation Overview:

As for product types, the COVID-19 mRNA Vaccines segment held the largest market share in 2021.

Key Companies in the global Nucleic Acid-based Therapeutics market covered in Chapter 3:

Akcea Therapeutics
Moderna Therapeutics
Alnylam Pharmaceuticals
Sarepta Therapeutics
Pfizer
Biogen
Novartis

In Chapter 4 and Chapter 14.2, on the basis of types, the Nucleic Acid-based Therapeutics market from 2018 to 2029 is primarily split into:

COVID-19 mRNA Vaccines
Other Nucleic Acid-based Therapeutics

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Nucleic Acid-based Therapeutics market from 2018 to 2029 covers:

Hospitals
Academic and Research Institutes

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)